Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2013) David Moher   ANNALS OF INTERNAL MEDICINE

Risk of Cardiovascular Events and All-Cause Mortality in Patients Treated With Thiazolidinediones in a Managed-Care Population

(2010) Debra A. Wertz et al.  

Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone

(2010) David J. Graham et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials

(2009) Jane L. Hutton   BRITISH JOURNAL OF HAEMATOLOGY

Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial

(2009) Philip D Home et al.   LANCET

Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone

(2008) Adrian V. Hernandez et al.   AMERICAN HEART JOURNAL

Comparison of Cardiovascular Outcomes in Elderly Patients With Diabetes Who Initiated Rosiglitazone vs Pioglitazone Therapy

(2008) Wolfgang C. Winkelmayer et al.   ARCHIVES OF INTERNAL MEDICINE

Cardiovascular Outcomes in Trials of Oral Diabetes Medications

(2008) Elizabeth Selvin et al.   ARCHIVES OF INTERNAL MEDICINE

The "number needed to treat" turns 20 -- and continues to be used and misused

(2008) F. A. McAlister   CANADIAN MEDICAL ASSOCIATION JOURNAL

Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis

(2008) Y. K. Loke et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2008) D. M. Nathan et al.   DIABETES CARE

Thiazolidinedione insulin sensitizers and the heart: a tale of two organs?

(2007) R. E. Buckingham et al.   DIABETES OBESITY & METABOLISM

National Cholesterol Education Program and International Diabetes Federation definitions of metabolic syndrome in the prediction of diabetes. Results from the FIrenze-Bagno A Ripoli study

(2007) E. Mannucci et al.   DIABETES OBESITY & METABOLISM